General Range

PERATUNE-TZ 2.25G

Fortune LabsPanchkula, Haryana

Price on request/100 · MOQ 100 boxes

PERATUNE-TZ 2.25G Injection by Fortune Labs contains Piperacillin 2 gm and Tazobactam 250 mg, a broad-spectrum antibiotic combination used to treat serious bacterial infections. Piperacillin is a penicillin-class antibiotic that inhibits bacterial cell wall synthesis, while Tazobactam helps protect it against certain bacterial beta-lactamase enzymes. PERATUNE-TZ may be prescribed for pneumonia, complicated urinary tract infections, intra-abdominal infections, and skin infections caused by susceptible bacteria. Available in a 2.25 gm single-dose vial, this formulation is part of Fortune Labs' injectable pharmaceutical portfolio. Fortune Labs offers Injection PCD Pharma Franchise and distribution opportunities across India. Contact the company for wholesale pricing, product availability, and franchise enquiries. Administer only under medical supervision.

CategoryGeneral Range

Min. Order100 boxes

Supplied byFortune Labs

CertificationWHO-GMP, ISO

Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.

View Company

Specifications

Composition: Piperacillin 2 gm + Tazobactam 250 mg
Packaging Type: Glass Vial with Diluent Ampoule and Outer Carton
Packaging Size: 2.25 gm Single-Dose Vial
Dosage Form: Injection (Powder for Reconstitution)
Treatment: Pneumonia, complicated urinary tract infections, intra-abdominal infections, skin and soft tissue infections, and other serious bacterial infections c
Shelf Life: 24 Months
Storage: Store below 30°C, protect from light & moisture
Certification: WHO-GMP, ISO

Company Info

Fortune LabsPanchkula, Haryana

View Full Profile

Fortune Labs is an Indian pharmaceutical and PCD (Propaganda Cum Distribution) pharma franchise company based in Panchkula, Haryana.

Key Details

• Headquarters: S.C.F 258, 1st Floor, Sector 16, Panchkula, Haryana, India
• Establishment: Founded in 2008 (sister concern of Prosperity 6 Pharmaceutics in Baddi)
• CEO / Leadership: Mayank Bansal
• Certifications: ISO 9001, WHO-GMP, and DCGI-approved formulations
• Business Model: Offers Pan-India PCD pharma franchises with monopoly rights, third-party manufacturing, and marketing support.

Product Portfolio & Therapeutic Ranges

• Formulations: Tablets, capsules, syrups, dry powders, injectables, ointments, gels, eye/ear/nasal drops, softgel capsules, and Ayurvedic/herbal products.
• Therapeutic Segments: Antibiotics, cardiac and diabetic care, orthopedics, dermatology, gynaecology, paediatrics, gastrointestinal/PPI ranges, neurology, antihistamines/cough-cold, and nutritional supplements.
Would you like information on how to apply for a franchise partnership or specific product price lists from Fortune Labs?